S

Strand Therapeutics

102 employees

Strand Therapeutics is a biopharmaceutical company applying synthetic biology to RNA therapeutics to develop single dose mRNA treatments.

Basic info

Industry

biotechnology research

Sectors

Biotechnology
synthetic biology
biotechnology
Immunotherapy
Therapeutics
RNA therapeutics
Pharmaceutical
Life Science

Date founded

2017

Funding rounds raised

Total raised

$52M

from 13 investors over 13 rounds

S

Strand Therapeutics raised $45M on November 28, 2022

Investors: FPV Ventures, Playground Global and Potentum Partners

S

Strand Therapeutics raised $400K on November 9, 2021

Investors: National Cancer Institute

S

Strand Therapeutics raised $800K on August 4, 2021

Investors: National Cancer Institute

S

Strand Therapeutics raised $52M on June 23, 2021

Investors: Redmile Group, Camford Capital, BeiGene, Playground Global and ANRI

S

Strand Therapeutics raised $6M on June 4, 2019

Investors: Playground Global, ANRI and Creative Destruction Lab

FAQ